greeksoup/ stock research
Stock research / United States / SUPN / Planned sales

Supernus Pharmaceuticals, Inc. planned insider sales

In the twelve months since 11 October 2025 insiders at Supernus Pharmaceuticals, Inc. filed 11 Form 144 notices of planned sales, 201,381 shares worth $10.2 million at the time of filing, from 7 sellers. The latest, filed 17 March 2026: Padmanabh P Bhatt (officer), 57,250 shares worth $2.9 million, planned for around 17 March 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
17 March 2026Padmanabh P BhattOfficer57,250$2.9 million17 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
16 March 2026Padmanabh P BhattOfficer50,000$2.5 million16 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
13 March 2026The Kbt Trust U/A Dtd 12/30/2010Director, Officer35,000$1.8 million13 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
12 March 2026Frederick M HudsonDirector5,369$271,75212 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
10 March 2026William Todd HorichOfficer4,439$244,14510 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
9 March 2026Frank MottolaOfficer1,623$87,0749 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
9 March 2026William Todd HorichOfficer4,438$239,6529 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
6 March 2026Georges GemayelDirector8,787$465,7716 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered plan; Previously Exercised OptionsForm 144
5 March 2026Georges GemayelDirector10,000$537,1175 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesPreviously Exercised OptionsForm 144
19 February 2026Bethany SensenigDirector4,475$224,64519 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
19 December 2025Frank MottolaOfficer20,000$985,60019 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Supernus Pharmaceuticals, Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install